# Validity of the Electronic Self-Administered Gerocognitive Examination (eSAGE)

> **NCT02544074** · — · COMPLETED · sponsor: **Ohio State University** · enrollment: 69 (actual)

## Conditions studied

- Mild Cognitive Impairment
- Dementia

## Interventions

- **BEHAVIORAL:** neuropsychological testing
- **BEHAVIORAL:** eSAGE testing

## Key facts

- **NCT ID:** NCT02544074
- **Lead sponsor:** Ohio State University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2024-11-13
- **Final completion:** 2024-11-13
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2025-03-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02544074

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02544074, "Validity of the Electronic Self-Administered Gerocognitive Examination (eSAGE)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02544074. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*